Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.

Gold SM, Raji A, Huitinga I, Wiedemann K, Schulz KH, Heesen C.

J Neuroimmunol. 2005 Aug;165(1-2):186-91.

PMID:
15935481
2.

Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.

Heesen C, Gold SM, Huitinga I, Reul JM.

Psychoneuroendocrinology. 2007 Jul;32(6):604-18. Epub 2007 Jun 29. Review.

PMID:
17602841
3.

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis.

Vukusic S, Confavreux C.

J Neurol Sci. 2003 Feb 15;206(2):135-7. Review.

PMID:
12559500
4.

The hypothalamo-pituitary-adrenal axis in multiple sclerosis.

Huitinga I, Erkut ZA, van Beurden D, Swaab DF.

Ann N Y Acad Sci. 2003 May;992:118-28. Review.

PMID:
12794052
5.

The transition from relapsing-remitting MS to irreversible disability: clinical evaluation.

Trojano M, Paolicelli D, Bellacosa A, Cataldo S.

Neurol Sci. 2003 Dec;24 Suppl 5:S268-70. Review.

PMID:
14652786
6.

Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation.

Bomholt SF, Harbuz MS, Blackburn-Munro G, Blackburn-Munro RE.

Stress. 2004 Mar;7(1):1-14. Review.

PMID:
15204028
7.

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.

Langer-Gould A, Popat RA, Huang SM, Cobb K, Fontoura P, Gould MK, Nelson LM.

Arch Neurol. 2006 Dec;63(12):1686-91. Review.

PMID:
17172607
8.

Programming of the hypothalamo-pituitary-adrenal axis: serotonergic involvement.

Andrews MH, Matthews SG.

Stress. 2004 Mar;7(1):15-27. Review.

PMID:
15204029
9.

Multiple sclerosis.

Hawker K, Frohman E.

Prim Care. 2004 Mar;31(1):201-26. Review. No abstract available.

PMID:
15110166
10.

Natural history of multiple sclerosis: risk factors and prognostic indicators.

Vukusic S, Confavreux C.

Curr Opin Neurol. 2007 Jun;20(3):269-74. Review.

PMID:
17495619
11.
12.

Testing times for the hypothalamo-pituitary-adrenal axis.

Hindmarsh PC.

J Pediatr Endocrinol Metab. 2005 May;18(5):431-2. Review. No abstract available.

PMID:
15921171
13.

Trauma, stress and multiple sclerosis.

Martinelli V.

Neurol Sci. 2000;21(4 Suppl 2):S849-52. Review.

PMID:
11205361
14.

[Liver and endocrine system. Part II: pituitary-gonadal axis and adrenal gland activity disturbances].

Marek B, Buntner B, Kos-Kudła B, Ostrowska Z, Kajdaniuk D, Zwirska-Korczala K, Adamek B, Karasińska M.

Wiad Lek. 1998;51(7-8):352-9. Review. Polish.

PMID:
9748891
16.

The HPA axis, SNS, and immunity: a commentary.

Sheridan J.

Brain Behav Immun. 2003 Feb;17 Suppl 1:S17. Review. No abstract available.

PMID:
12688290
17.

Nursing grand rounds: multiple sclerosis.

Holland NJ, Madonna M.

J Neurosci Nurs. 2005 Feb;37(1):15-9. Review.

PMID:
15794440
18.

Stress regulation in multiple sclerosis: current issues and concepts.

Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, Gold SM.

Mult Scler. 2007 Mar;13(2):143-8. Epub 2007 Jan 29. Review.

PMID:
17439878
19.

Multiple sclerosis.

Campion K.

Prof Nurse. 1997 Dec;13(3):169-72. Review. No abstract available.

PMID:
9439229
20.

Developing Biomarkers for MS.

Gnanapavan S, Giovannoni G.

Curr Top Behav Neurosci. 2015;26:179-94. doi: 10.1007/7854_2014_362. Review.

PMID:
25502545

Supplemental Content

Support Center